Asset Planning Services (Pennsylvania)’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
– Sell
-2,474
Closed -$84K – 201
2019
Q3
$84K Buy
2,474
+2
+0.1% +$73 0.04% 105
2019
Q2
$102K Buy
2,472
+2
+0.1% +$79 0.04% 99
2019
Q1
$100K Sell
2,470
-403
-14% -$16.1K 0.05% 99
2018
Q4
$119K Buy
2,873
+16
+0.6% +$664 0.06% 81
2018
Q3
$120K Buy
2,857
+16
+0.6% +$616 0.06% 83
2018
Q2
$98K Sell
2,841
-229
-7% -$7.83K 0.05% 94
2018
Q1
$103K Buy
3,070
+19
+0.6% +$653 0.05% 93
2017
Q4
$105K Buy
3,051
+18
+0.6% +$614 0.05% 101
2017
Q3
$103K Buy
3,033
+177
+6% +$5.69K 0.06% 106
2017
Q2
$91K Sell
2,856
-265
-8% -$8.36K 0.06% 108
2017
Q1
$101K Buy
3,121
+145
+5% +$4.57K 0.07% 107
2016
Q4
$92K Buy
2,976
+18
+0.6% +$550 0.07% 98
2016
Q3
$95K Buy
2,958
+16
+0.5% +$535 0.08% 95
2016
Q2
$98K Sell
2,942
-36
-1% -$1.15K 0.08% 102
2016
Q1
$84K Buy
2,978
+19
+0.6% +$543 0.08% 113
2015
Q4
$91K Buy
2,959
+69
+2% +$2.17K 0.09% 86
2015
Q3
$86K Buy
2,890
+16
+0.6% +$513 0.09% 81
2015
Q2
$91K Buy
+2,874
New +$93.7K 0.09% 83

Other funds holding PFE

Asset Planning Services (Pennsylvania)'s PFE Position: Q4 2019 in Review

Asset Planning Services (Pennsylvania) sold out of Pfizer (PFE) in Q4 2019, closing a stake of 2,474 shares — an estimated $84K sold.

Asset Planning Services (Pennsylvania) first reported a position in PFE in Q2 2015 and held it in 18 quarters. The position peaked at $120K in Q3 2018. 2,526 funds tracked by Wall St. Rank hold PFE as of Q4 2019.

  • Asset Planning Services (Pennsylvania) reported no remaining Pfizer position as of Q4 2019 after selling out during the quarter.
  • Asset Planning Services (Pennsylvania) sold 2,474 Pfizer shares in Q4 2019, an estimated $84K.
  • Asset Planning Services (Pennsylvania) first reported a position in Pfizer in Q2 2015 and held it in 18 quarters.
  • Asset Planning Services (Pennsylvania)'s Pfizer position peaked at $120K in Q3 2018.
  • 2,526 funds tracked by Wall St. Rank held Pfizer as of Q4 2019.

Based on Asset Planning Services (Pennsylvania)'s 13F filing for Q4 2019, filed 12 Feb 2020.